Tirzepatide 12.5MG 4S
Ended Awarded Last action
- Contract number
- SPE2DR26FX0ET
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,346
Award facts
- Contract value 100% obligated
- $43,346.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $43,346.40 to AmerisourceBergen Drug Corp for Tirzepatide 12.5mg pharmaceutical supplies. The contract, issued on January 28, 2026, with completion targeted for February 25, 2026, carries firm fixed-price terms and was competitively awarded with no set-aside designation. Performance will occur at the awardee's facility in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for supplying comprehensive pharmaceutical and medical commodities to military healthcare systems globally.
Tirzepatide is a diabetes medication used to treat Type 2 diabetes and support weight management, making this procurement consistent with DLA's mission to supply essential pharmaceutical products for military treatment facilities and veterans' healthcare programs. AmerisourceBergen's extensive federal contract portfolio demonstrates proven capability in delivering specialty medications, vaccines, and medical supplies across multiple therapeutic domains to support Department of Defense healthcare operations worldwide. The competitive award reflects the contractor's established standing within the federal medical supply chain and capacity to efficiently fulfill government pharmaceutical procurement requirements.
Quick answers
Who was awarded contract SPE2DR26FX0ET?
SPE2DR26FX0ET was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FX0ET worth?
The government has obligated $43,346 on SPE2DR26FX0ET.
Is contract SPE2DR26FX0ET an order under another contract?
Yes. SPE2DR26FX0ET is a delivery order under SPE2DR25D7062, an indefinite delivery contract.
Was contract SPE2DR26FX0ET competed?
The extent of competition for SPE2DR26FX0ET was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award